Professor Arnon Nagler, MD, MSc is one of the world’s foremost experts in CAR-T cell therapy, hematology, and stem cell transplantation. As Director of the Hematology Division and Bone Marrow Transplantation Unit at Sheba Medical Center, Prof. Nagler leads one of the most advanced CAR-T programs in Europe and the Middle East.
A pioneer in clinical CAR-T therapy for leukemia, lymphoma, and multiple myeloma, Prof. Nagler has helped position Sheba as a global destination for patients seeking cutting-edge, personalized treatments.
Under his leadership, Sheba became one of the first hospitals in the region to offer CAR-T therapy to international patients—delivering outstanding results, even for patients who had exhausted all other options.
Prof. Nagler graduated from the Hebrew University–Hadassah Medical School, earned an MSc in hematopoiesis from Tel Aviv University, and trained in bone marrow transplantation at Stanford University. He has authored over 600 scientific publications and is recognized globally for advancing the fields of cellular immunotherapy and transplantation.
He has held prominent roles in international medical organizations, including:
- Chair of the Acute Leukemia Working Party (EBMT)
- Vice-Chair of the EBMT Scientific Council
- Scientific Program Committee Member of the European Hematology Association (EHA)
At Israeli Hospitals Ltd., we work closely with Prof. Nagler and Sheba’s CAR-T team to offer patients from around the world access to this life-saving therapy.
We guide families through the process—from case evaluation to arrival in Israel—with full support every step of the way. If you're searching for the most advanced CAR-T treatment options available, Prof. Arnon Nagler is one of the leading experts in the world.
Tanya from Israeli Hospitals with Prof. Arnon Nagler
Publication date: July 2025
